TherapeuticsMD, Inc. (TXMD) Stock Price

TXMDStock
$2.28+88.20%52W
Market Cap$26.39M
P/E
PEG Ratio
Div yield
Beta0.67

TXMD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-22.02%
Price vs S&P 500 (4W)-2.57%
VGM Score59.67

TXMD Earnings Surprise History

Q3 22-3.13est. -2.04
Q4 228.23est. -1.11
Q1 23-0.24est. 0.06
Q2 23-0.24est. -0.07

TXMD Analyst Recommendations

Nov 2023
Dec 2023
Jan 2024
Feb 2024
2.17
2.17
2.17
2.17

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
TXMDTherapeuticsMD, Inc.
BCB$2.28
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About TherapeuticsMD, Inc.

TherapeuticsMD is a pharmaceutical royalty company that generates revenue from women's health products licensed to Mayne Pharma for U.S. commercialization, including IMVEXXY, BIJUVA, ANNOVERA, and prescription prenatal vitamins. By licensing its portfolio to an established pharmaceutical partner, the company collects royalties while minimizing operational expenses.